Treatment of Rare Systemic Autoimmune Rheumatic Diseases (SARDS): Systemic Lupus Erythematous (SLE) and Idiopathic Inflammatory Myopathies

Kostas N. Botsoglou, MD, provides an overview of systemic autoimmune rheumatic diseases (SARDs) or connective tissue diseases by discussing their overall characteristics, common comorbidities, and impact on patient quality of life.

An expert rheumatologist shares key insights into common causes, typical presentation, and differential diagnosis of systemic lupus erythematous (SLE) and idiopathic inflammatory myopathies.

A key opinion leader in rheumatology discusses the goals of therapy for SARDs and provides an overview of current approaches to treatment including the use of NSAIDs, corticosteroids, and immunosuppressive agents.

An expert in rheumatic diseases considers therapeutic options for the treatment of SARDS including subcutaneous and intramuscular formulations of Repository Corticotropin Injection as well as immunosuppressive agents.

A thought leader in rheumatology, Kostas N. Botsoglou, MD, highlights the importance of individualizing therapy for SARDs and shares insight into novel treatments on the horizon that may address current unmet needs.